A list of all funded projects 2014-2017 is available here

Irish funding success in Horizon 2020

2017:  €12.5 million for Irish Health Research in year four of Horizon 2020

A list of all successful projects is available here.

Irish health researchers have secured 2.58% (€12,551,122) of the total available budget for 2017 (the lowest budget available to date of the four years), exceeding the 1.5% target and also the stretched 2% target. There was a decrease in the 2017 budget compared to the 2016 budget and a two-stage process was introduced for a small number of calls.

A total of 10 projects including one R&I coordinator and two SME instrument coordinators were funded.

The  coordinator for the R&I grant is:

Annette Byrne, RCSI with a project entitled ‘Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based stratification solutions’ COLOSSUS. Other Irish partners on the project are UCD, ICORG (now Cancer Trials Ireland) and Pintail. The project has been awarded a total of €5,996,359.5 with €2,115,683 coming to Ireland.

There are a further seven successful projects with Irish researchers as partners including the Health Research Board as a successful partner in an ERA NET call under ICPerMed.

1. ERA PerMed, ERA-Net Cofund in Personalised Medicine, HRB (Mairead O’Driscoll) 551,250. This project will fund topicsidentified in the Strategic Research and Innovation agenda in Personalised Medicine and the Action Plan of ICPerMed (of which Mairead O’Driscoll is Chair). ERA PerMed will coordinate, plan, implement and monitor joint transnational calls of the participating partners (funding agencies from EU, associate countries and third countries).

2. CAPTAIN, Coach Assistant via Projected and Tangible Interface, DCU (Unai Diaz-Orueta) €291,312. This call was on personalised coaching for well-being and care of people as they age and was very popular. There were 24 applications from Ireland including 4 coordinators to this call. 

3. INSIST, IN-Silico trials for treatment of acute Ischemic Stroke, Neuravi Limited, €416,275, NUI Galway (Pat McGarry), €425,365.

4. InSiSt, InSiSt: In-silico trials for drug-eluting BVS design, development and evaluation, NUI Galway (Ted Vaughan),566,825, Boston Scientific €306,250.

5. TUDCA-ALS, Safety and efficiency of tauroursodeoxycholic acid  (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS), TCD (Orla Hardiman), 351,086. 

6. HIPGEN, Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicentre phase II trial, ICON Clinical Research Limited, €1,250,000. Clinical research on regenerative medicine call.

7. PRECISE4Q, Personalised Medicine by Predictive Modeling in Stroke for better Quality of Life. DIT, John Kelleher. €1,278,750.
 

There were also two SMEs who were successful in the Phase 2 round of the SME Instrument call which were awarded almost €5 million which makes up 44% of the total funding awarded.

1. EASIVIRAL, Altratech Limited, 2,969,000.

Altratech is a Limerick based company which develops single-use portable semiconductor test kit for "point of care" testing of infectious viral diseases. The Horizon 2020 funding will be used to fund a  project to deliver a point of care HIV test kit to improve the prognosis and health of HIV patients.

2. BIOSIM, Valitacell Ltd, Accelerating the commercialisation of a disruptive analytical  technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence €2,029,325.

 The Horizon 2020 award will fund the advancement and commercialisation of Valitacell’s ‘ChemStress’ technology – a novel disruptive product which enables biopharmaceutical companies to manufacture life-saving drugs, cheaper, faster and with more regulatory confidence.

 

Close

2016: €7.8 million for Irish Health Research in year three of Horizon 2020

A list of all successful projects is available here.

Irish health researchers have secured €7,827,218 of the available health budget for 2016 and continue to be very successful in Horizon 2020.

A total of 13 projects including one R&I coordinator and one SME instrument coordinator were funded.

The Coordinator for the R&I grant is:

  • Professor Ruairi Brugha, Royal College of Surgeons with a project on scaling up safe surgery for district and rural populations in Africa. (€1.6 million).

 SME Coordinator (SME Instrument Phase 2)

  • SiriusXT, a high throughput bench-top, Soft X-Ray Microscope – The SXT100. The only high throughput lab based solution for imaging subcellular structures (€3 million).

A list of all 13 projects is available to download below.

The Department of Health and health agencies are continuing to play an important role as successful partners in EU research teams. The Health Research Board is a partner in a project on building sustainable and resilient health system models. The HSE and Department of Health are involved in a new initiative on Human Biomonitoring to monitor and carry out scientific assessment of human exposures to chemicals and potential health impacts in Europe.

Ireland is competing strongly in the area of ‘Big Data supporting Public Health policies.’ Two successful Irish projects in this area were the top two ranked projects in the EU. One of the projects with Irish partners from UCD and Children’s University Hospital is on Big data for Childhood obesity. Big Data infrastructures allow the engagement of European citizens in the data collection process, allowing reshaping of policies at a regional, national and European level. This will be facilitated through the development of a platform, allowing the quantification of behavioural community patterns through Big Data provided by wearables and eHealth devices. The project will reach out to more than 25,000 school and age-matched obese children and adolescents across Europe as sources for community data.

The other project is led by University of Ulster and involves making better use of healthcare data. DCU and IBM Ireland are partners in this project. The project will use hardware and software solutions to connect fragmented health data and enable policymakers to use it.

Irish health researchers are successfully competing at the highest level for EU funding.  These latest results show Irish research institutions, SMEs, hospitals, multinationals and public agencies now working in high-calibre health research collaborations with our European counterparts.

Close

2015: €14.8 million for Irish health researchers in year two of H2020

A list of all successful projects is available here.

Irish health researchers have secured 2.49 % of the available health budget, exceeding the 1.5% HRB bottom up target of €8.15m and the 2% stretched target of €10.87m. These targets were set as part of an ambitious national target adopted to draw down €1.25b in funding over the seven years of the programme.

A total of 12 projects including two R&I coordinators and four SME instrument coordinators have been funded.

The two coordinators for R&I grants were:

  • Dr Mary Murphy, REMEDI, NUI Galway with a project on the development of closed, scalable and automated robotic systems for therapeutic stem-cell manufacturing. (€2.99 million).
  • Dr John Dinsmore, Health Innovation Lead/Deputy Director, Trinity Centre for Practice & Healthcare Innovation (TCPHI), School of Nursing and Midwifery, Trinity College Dublin. (€2.55 million).

Irish SME’s performed well in the new SME instrument topic on the validation of biomarkers and/or diagnostic medical devices. Four SME’s won a little over €7 million between them with Irish coordinators in Phase 1 and Phase 2:

Phase 1:

  • Hibergene Diagnostics Limited, Real time molecular diagnostic testing for human infectious diseases using LAMP (Loop Mediated Isothermal Amplification) technology (€50,000).
  • Atturos, Strategic planning for commercialisation of a multiplexed protein diagnostic (Dx) blood test for Organ-Confined Prostate Cancer (€50,000).

Phase 2:

  • Oncomark Ltd (Mairin Rafferty/Liam Gallagher), Novel Prognostic Assay for Early Stage Breast Cancer (2.75 million).
  • PMD Device Solutions (Myles Murray), Enabling 70% of patient population to be continuously monitored leading to a 20% reduction in adverse respiratory compromised patient events (€4.2 million).

A list of all 12 successful projects is available to download below.

Ireland is performing very well in health for a second year despite a 25% increase in applications to the first stage of the two-stage call compared to 2014 coupled with a reduction in the total budget available.

In 2015, there were only two coordinators funded in R&I proposals compared to 4 in 2014 but they received only slightly less funding than the four in 2014. The two SME Instrument coordinators funded, received more funding than the two funded in 2014 (approximately €7m compared with approximately €5m in 2014). There were about half the number of partners funded in proposals coordinated from outside Ireland compared to 2014.

New instruments such as Pre Commercial Procurement have been funded with ICT for Health and the SME instrument still doing well in 2015.

Close

2014: €16.2 million for Irish health research in H2020's first year

A list of all 23 successful projects is available here.

Irish health researchers have secured 2.75% of the available health budget. A total of 23 projects including four R&I coordinators and five SME Instrument coordinators have been funded.

The four coordinators for R&I grants were:

  • Professor Tim O’Brien, REMEDI, NUI Galway with a project on a clinical trial in the area of diabetic complications. (€2 million)
  • Professor Frank Barry, REMEDI, NUI Galway with a clinical trial using adult stem cells to treat knee osteoarthritis. (€1.7 million)
  • Dr Dympna Casey, School of Nursing & Midwifery, NUI Galway, her project deals with managing active and healthy ageing with the use of caring service robotics. (€687,500)
  • Dr Kieran Moran, School of Health & Human Performance, Dublin City University, whose project targets personalised health care for cardiac rehabilitation, through technology enabled Connected Health. (€1.3 million)

Irish SMEs performed well in the new SME Instrument topic on the validation of biomarkers. Five SMEs won €5.3 million between them, with Irish coordinators in Phase1 and Phase 2:

Phase 1:

  • BlueBridge Technologies, A device that will dramatically improve the protection of babies during birth. It will monitor the child continuously with better acuity, resulting in better clinical outcomes at a lower cost. (€50k)
  • Vitalograph, An integrated automated ECG diagnostics platform to improve cardiac safety in clinical drug trials (€50k)
  • Inform Bio, PreEclampsia diagnosis by Early Kidney Injury Detection (€50k)

Phase 2

  • Radisens Diagnostics Ltd, Moving to Efficient Diabetes care: Multimode integrated CO-morbidity diagnostics platform (€4.5m)
  • Biosensia, Advanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach (€0.6m) (joint coordinator)

There has been a large increase in the number of applications from Irish coordinators. There were 56 Irish coordinator applicants during 2014.  By comparison, in FP7 the highest number of Irish coordinator applications in any one year was 14. This was in 2012. There were 69 Irish coordinator applicants during the entire seven-year lifetime of FP7.

Close

Irish funding success in Framework Programme 7 (FP7)

The FP7 programme has now finished. This funding programme ran from 2007-2013, with €6 billion allocated for health research. To the end of FP7 (2007-2013) over €80 million has been secured by Irish researchers and 29 Irish led proposals have been funded.

Information about the overall programme is available from the European Commission website http://cordis.europa.eu/fp7/home_en.html.

A detailed list of successful Irish coordinators and partners funded under FP7 Health from 2007 to 2013 is available in the following document.